Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV

The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.

  •   Table of Contents

Download Guidelines

Financial Disclosure

Financial Disclosure (Reporting Period: February 2017 to February 2018)
Panel Member Status Company (Relationship)
Judith Aberg M
  • Gilead (Advisory Board, Research Support)
  • Janssen (Advisory Board)
  • Merck (Advisory Board)
  • ViiV (Advisory Board, Research Support)
Adaora Adimora M
  • Gilead (Research Support)
  • Merck (Advisory Board)
Allison Agwu M
  • Gilead (Advisory Board)
Curt Beckwith M
  • Gilead (Research Support)
  • Cepheid (Research Support)
Roger Bedimo M
  • Bristol-Myers Squibb (Research Support)
  • Gilead (Advisory Board)
  • Merck (Advisory Board, Research Support)
  • Theratechnologies (Advisory Board)
  • ViiV (Advisory Board)
John T. Brooks
M None
R. Douglas Bruce M None
Danielle Campbell M None
J. Kevin Carmichael M None
Geetanjali Chander M None
Laura Cheever M None
Susan Cu-Uvin M
  • Gilead (Advisory Board)
Eric Daar M
  • Gilead (Consultant, Research Support)
  • Merck (Consultant, Research Support)
  • Theratechnologies (Consultant)
  • ViiV (Consultant, Research Support)
David Evans M
  • Gilead (Advisory Board)
  • Merck (Advisory Board)
  • ViiV (Advisory Board)
Rajesh Gandhi M
  • Gilead (Educational Grant)
  • Merck (Educational Grant)
  • ViiV (Educational Grant)
  • Theratechnologies (Advisory Board)
Stephen J. Gange M None
Edward Gardner M None
Thomas Giordano M None
David Glidden M
  • Gilead (Advisory Board)
  • GlaxoSmithKline (Consultant on Aaron Diamond AIDS Research Center PrEP Study, funded by GlaxoSmithKline)
Roy M. Gulick C None
Tim Horn M None
Peter Hunt M
  • ViiV (Consultant)
Steven Johnson M
  • ViiV (Advisory Board)
Rami Kantor M
  • Gilead (Advisory Board)
Andy Kaytes M
  • ViiV (Travel Support, ViiV Community Summit)
Marla J. Keller M None
Michael Kozal M
  • AbbVie*
  • Bristol-Myers Squibb*
  • Gilead*
  • ViiV*
* Yale University receives grant support from these companies for studies where Dr. Kozal served or serves as PI. Dr. Kozal is an employee of the federal government and does not receive any financial support from these grants.
H. Clifford Lane C None
Jeffrey Lennox M None
Henry Masur M None
Susanna Naggie M
  • Abbvie (Research Support)
  • Bristol-Myers Squibb (Research Support)
  • Gilead (Research Support)
  • Janssen (Research Support)
  • Merck (Research Support)
  • Tacere Therapeutics (Research Support)
Alice K. Pau ES None
Tonia Poteat M
  • Gilead (Research Support)
  • ViiV (Research Support)
Asa Radix M None
James Raper M None
Daniel Reirden M
None
Kimberly Scarsi M None
Virginia Sheikh M None
Serena Spudich M None
Kimberly Struble M None
Susan Swindells M
  • Merck (Research Support)
  • ViiV (Research Support)
Pablo Tebas M
  • Gilead (Research Support, Consultant)
  • Merck (Research Support, Consultant)
  • ViiV (Research Support, Consultant)
Melanie Thompson M
  • Bristol-Myers Squibb (Research Support)
  • CytoDyn, Inc. (Research Support)
  • Gilead (Research Support)
  • GlaxoSmithKline (Research Support)
  • Merck (Research Support)
  • Roche Molecular Diagnostics (Research Support)
  • TaiMed (Research Support)
  • ViiV (Research Support)
Phyllis Tien M
  • Merck (Research Support)
  • Theratechnologies (Research Support)
Steven Vargas M None
Rochelle Walensky M None
Key to Acronyms: C = Co-Chair; ES = Executive Secretary; M = Member; PI = Principal Investigator

Download Guidelines